Tamoxifen induced-non-alcoholic steatohepatitis (NASH): Has the time come for the oncologist to be diabetologist
- 2 December 2005
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 97 (2) , 223-224
- https://doi.org/10.1007/s10549-005-9104-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Non‐alcoholic SteatohepatitisPublished by Wiley ,2005
- The Effect of Exemestane on the Lipidemic Profile of Postmenopausal Early Breast Cancer Patients: Preliminary Results of the TEAM Greek Sub-studyBreast Cancer Research and Treatment, 2005
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyGastroenterology, 2005
- Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver DiseaseGastroenterology, 2005
- Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trialBMJ, 2005
- Invasive and non-invasive investigations for non-alcoholic steatohepatitis: The benefit of histologyScandinavian Journal of Gastroenterology, 2005
- Global Prevalence of DiabetesDiabetes Care, 2004
- Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient miceJournal of Clinical Investigation, 2000